Carbon ion beam combined with chemotherapy distroys pancreatic cancer stem cells

Pancreatology ◽  
2016 ◽  
Vol 16 (4) ◽  
pp. S168
Author(s):  
Cui Xing
2021 ◽  
Vol Volume 14 ◽  
pp. 4749-4760
Author(s):  
Sei Sai ◽  
Eun Ho Kim ◽  
Woong Sub Koom ◽  
Guillaume Vares ◽  
Masao Suzuki ◽  
...  

2011 ◽  
Vol 71 (10) ◽  
pp. 3676-3687 ◽  
Author(s):  
Xing Cui ◽  
Kazuhiko Oonishi ◽  
Hirohiko Tsujii ◽  
Takeshi Yasuda ◽  
Yoshitaka Matsumoto ◽  
...  

2015 ◽  
Vol 34 (5) ◽  
pp. 2233-2237 ◽  
Author(s):  
SUNG-JAE BAEK ◽  
HIDESHI ISHII ◽  
KEISUKE TAMARI ◽  
KAZUHIKO HAYASHI ◽  
NAOHIRO NISHIDA ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Claudia Di Carlo ◽  
Bebiana C. Sousa ◽  
Marcello Manfredi ◽  
Jessica Brandi ◽  
Elisa Dalla Pozza ◽  
...  

AbstractPancreatic cancer stem cells (PCSCs) play a key role in the aggressiveness of pancreatic ductal adenocarcinomas (PDAC); however, little is known about their signaling and metabolic pathways. Here we show that PCSCs have specific and common proteome and lipidome modulations. PCSCs displayed downregulation of lactate dehydrogenase A chain, and upregulation of trifunctional enzyme subunit alpha. The upregulated proteins of PCSCs are mainly involved in fatty acid (FA) elongation and biosynthesis of unsaturated FAs. Accordingly, lipidomics reveals an increase in long and very long-chain unsaturated FAs, which are products of fatty acid elongase-5 predicted as a key gene. Moreover, lipidomics showed the induction in PCSCs of molecular species of cardiolipin with mixed incorporation of 16:0, 18:1, and 18:2 acyl chains. Our data indicate a crucial role of FA elongation and alteration in cardiolipin acyl chain composition in PCSCs, representing attractive therapeutic targets in PDAC.


2012 ◽  
Vol 142 (5) ◽  
pp. S-50-S-51
Author(s):  
Christina Vorvis ◽  
George A. Poultsides ◽  
Jeffrey A. Norton ◽  
Maria Hatziapostolou ◽  
Dimitrios Iliopoulos

Sign in / Sign up

Export Citation Format

Share Document